Skip to main content
Log in

Posttreatment PET-CT-Confirmed Intrahepatic Radioembolization Performed Without Coil Embolization, by Using the Antireflux Surefire Infusion System

  • Case Report
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

An Erratum to this article was published on 17 August 2013

Abstract

Intra-arterial radioembolization with yttrium-90 microspheres is a safe and effective treatment option for patients with unresectable liver tumors. Pretreatment coil embolization of extrahepatic vessels is recommended to avoid extrahepatic deposition of radioactive microspheres. A novel infusion system with an expandable tip, the Surefire Infusion System (SIS), has recently been developed to minimize reflux. We report three cases of radioembolization with the use of the SIS. In all cases, yttrium-90 radioembolization was performed successfully without coil embolization of extrahepatic vessels. In all patients, positron emission tomography-computed tomography confirmed intrahepatic biodistribution of the microspheres in all targeted liver segments, and no extrahepatic deposition. With the use of the SIS, the need for coil embolization of extrahepatic vessels might be eliminated, and treatment may be extended to patients who were previously deemed unfit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Vente MA, Wondergem M, van der Tweel I et al (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959

    Article  CAS  PubMed  Google Scholar 

  2. Yip D, Allen R, Ashton C, Jain S (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349

    Article  PubMed  Google Scholar 

  3. Lam MG, Banerjee S, Louie JD et al (2013) Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0579-1

  4. Kennedy A, Coldwell D, Sangro B et al (2012) Radioembolization for the treatment of liver tumors general principles. Am J Clin Oncol 35:91–99

    Article  PubMed  Google Scholar 

  5. Ahmadzadehfar HSA, Reichmann K, Muckle M et al (2011) Imaging of Y90 distribution with PET/CT and bremsstrahlung SPECT/CT after radioembolization: a patient based study. J Nucl Med 52(suppl 1):92

    Google Scholar 

  6. Riaz A, Lewandowski RJ, Kulik LM et al (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20:1121–1130

    Article  PubMed  Google Scholar 

  7. Wright CL, Werner JD, Tran JM et al (2012) Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review. J Vasc Interv Radiol 23:669–674

    Article  PubMed  Google Scholar 

  8. Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23

    Article  PubMed  Google Scholar 

  9. Gates VL, Esmail AA, Marshall K et al (2011) Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med 52:72–76

    Article  PubMed  Google Scholar 

  10. Elschot M, Vermolen BJ, Lam MG et al (2013) Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS One 8:e55742

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Rose SC, Kikolski SG, Chomas JE (2012) Downstream hepatic arterial blood pressure changes caused by deployment of the Surefire AntiReflux expandable tip. Cardiovasc Intervent Radiol. doi:10.1007/s00270-012-0538-2

  12. Song SY, Chung JW, Kwon JW et al (2002) Collateral pathways in patients with celiac axis stenosis: angiographic–spiral CT correlation. Radiographics 22:881–893

    Article  PubMed  Google Scholar 

  13. Arepally A, Chomas J, Kraitchman D, Hong K (2013) Quantification and reduction of reflux during embolotherapy using an AntiReflux catheter and Tantalum microspheres: ex vivo analysis. J Vasc Interv Radiol 24:575–580

    Article  PubMed  Google Scholar 

  14. Louie JD, Wang EA, Broadwell S et al (2012) First in man experience with the surefire infusion system: a dedicated microcatheter system to eliminate reflux during embolotherapy. J Vasc Interv Radiol 23(suppl):80

    Google Scholar 

Download references

Conflict of interest

Andor F. van den Hoven, Jip F. Prince, Morsal Samim, Bernard A. Zonneberg, Marnix G. E. H. Lam, and Maurice A. A. J. van den Bosch have no conflict of interest. Aravind Arepally has indicated that he is consultant for Surefire Medical Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andor F. van den Hoven.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van den Hoven, A.F., Prince, J.F., Samim, M. et al. Posttreatment PET-CT-Confirmed Intrahepatic Radioembolization Performed Without Coil Embolization, by Using the Antireflux Surefire Infusion System. Cardiovasc Intervent Radiol 37, 523–528 (2014). https://doi.org/10.1007/s00270-013-0674-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-013-0674-3

Keywords

Navigation